Alafi Capital related stories
All articles and analysis
Formation 8, Foundation Capital co-lead $32.3 mln funding in Bolt ThreadsFormation 8 and Foundation Capital have co-led a $32.3 million Series B funding round in Bolt Threads, which makes silk fibers based on proteins found in nature. Founders Fund participated in the funding. Bolt Threads, which has emerged from stealth, has raised a total of $40 million, including a Series A funding led by Foundation Capital.
- Claremont Creek gets Harvard backing
Former US vice presidential candidate Nat Goldhaber has raised $125m for the debut fund from Claremont Creek Ventures. Harvard Management and the Regents of the University of California are among the fund’s backers.
- Deal Round-up 19/11/01
Ratos exits Telelogic; Wireless start-up secures third round funding.
- Deal Round-up 06/06/01
3G LAB picks up further funding from 3i; Mergermarket gets first round and valuation jump; Screentec moves out from Bayer’s shadow; ECI gets set to buy and build in UK dental health sector; 3G Idesta picks up E10m.
- Deal Round-up 06/06/01
3G LAB picks up further funding from 3i; Mergermarket gets first round and valuation jump; Screentec moves out from Bayer’s shadow; ECI gets set to buy and build in UK dental health sector; 3G Idesta picks up E10m.
- ISTO Tech Seeks Late-Stage VC, Eyes IPO
ISTO Technologies provides hope for anyone with knee injuries or back pain. ISTO, of St. Louis, has developed cell technology to help repair the cartilage of the knee, back or spine. Dr. Mitchell Seyedin, ISTO’s president and CEO, said the company will be looking for a late-stage investor, or mezzanine funding, later this year. Seyedin, who was speaking Thursday at the BMO Healthcare Conference in New York, didn’t disclose how much ISTO will be seeking. ISTO has raised $45 million through five rounds of funding, from Ascension Health Ventures, Alafi Capital, Life Sciences Partners, Mid-America Transplant Services and Zimmer Holdings.
- Kreatech Diagnostics Raises €2 Million
Kreatech Diagnostics, a Dutch molecular diagnostics startup, has raised €2 million in new VC funding. Alafi Capital was joined by return backer LSP. The company also named Kees Moonen, former CEO of Green Cross Vaccine, as its new CEO.